
Halozyme
Boston, MA, United States elektrofi.com
From their website, Nov 2026
Work here? Claim this listing
- GMP
About
Halozyme’s Elektrofi unit develops formulation technology for biologic therapies, focusing on low-volume, stable, hyper-concentrated subcutaneous delivery. It works with biopharmaceutical partners on protein therapeutics and related drug-product formats.
Services
Biologic formulation development
Develops low-volume, stable, hyper-concentrated biologic formulations for subcutaneous delivery.
Subcutaneous delivery enablement
Supports conversion of biologic therapies from intravenous administration to subcutaneous administration.
Asset-specific formulation customization
Creates molecule- and asset-specific formulations for nearly any protein therapeutic.
Delivery-format compatibility support
Develops formulations compatible with vials, pre-filled syringes, cartridges, and auto-injectors.
Formulation technology development
Develops hyper concentrated microparticle formulations for biologic therapies.
Partnered drug development
Collaborates with biopharmaceutical companies on development programs for biologic therapies.
Commercial-scale GMP manufacturing capacity development
States plans to establish Ph3 and commercial-scale GMP manufacturing capacity.
- Turnaround
- Done in seconds, not hours
Capabilities
- Scale and capacity
- Up to 500 mg/ml · Ph3 and commercial-scale GMP manufacturing capacity · Ph3 manufacturing capacity · Commercial-scale GMP manufacturing lines
Modalities and species
- Modalities
- Antibody · Cell therapy
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: manufacturing capacity
Industries served
- Biotech
Locations
- Based in
- Boston, MA, United States
- Sites
- Boston, United States
- Serves
- global
Public records
- Parent company
- HALOZYME THERAPEUTICS, INC. · US GLEIF
Similar labs
Work here? Claim this listing